,Column Name,User Defined ID,Name,Description,Measurement Technique,Study ID,Protocol ID(s)
0,-,PMID33767426_experimentID-01,Flow cytometry,-,Flow Cytometry,PMID33767426_study-01,PMID33767426_protocol-01
1,-,PMID33767426_experimentID-02,Total RNA extraction and RT–qPCR,-,PCR,PMID33767426_study-01,PMID33767426_protocol-01
2,-,PMID33767426_experimentID-03,Immunoprecipitation and immunoblot,-,Western Blot,PMID33767426_study-01,PMID33767426_protocol-01
3,-,PMID33767426_experimentID-04,Microscopy,-,Microscopy,PMID33767426_study-01,PMID33767426_protocol-01
4,-,PMID33767426_experimentID-05,Phospho-proteomics,-,Mass Spectrometry,PMID33767426_study-01,PMID33767426_protocol-01
5,-,PMID33767426_experimentID-06,In vitro kinase assay,-,Chemiluminescent Assay,PMID33767426_study-01,PMID33767426_protocol-01
6,-,PMID34133941_experimentID-01,Elisa,-,ELISA,PMID34133941_study-01,PMID34133941_protocol-01
7,-,PMID34133941_experimentID-02,Pseudovirus neutralization assay,-,Pseudovirus Neutralization Assay,PMID34133941_study-01,PMID34133941_protocol-01
8,-,PMID34133941_experimentID-03,IFN-γ ELISPOT,-,ELISPOT,PMID34133941_study-01,PMID34133941_protocol-01
9,-,PMID34133941_experimentID-04,IL-4 ELISPOT,-,ELISPOT,PMID34133941_study-01,PMID34133941_protocol-01
10,-,PMID34133941_experimentID-05,B cell immunophenotyping,-,Flow Cytometry,PMID34133941_study-01,PMID34133941_protocol-01
11,-,PMID34133941_experimentID-06,Comparative pathology of vaccinated and unvaccinated animals,-,Histopathology,PMID34133941_study-01,PMID34133941_protocol-01
12,-,PMID34688034_experimentID-01,ELISA RBD,-,ELISA,PMID34688034_study-01,PMID34688034_protocol-01
13,-,PMID34688034_experimentID-02,ELISA Spike,-,ELISA,PMID34688034_study-01,PMID34688034_protocol-01
14,-,PMID34688034_experimentID-03,Live SARS-CoV-2 microneutralization assay,-,Neutralizing Antibody Titer Assay,PMID34688034_study-01,PMID34688034_protocol-01
15,-,PMID35764089_experimentID-01,"SARS-CoV-2 ELISA, pre-vaccination",-,ELISA,PMID35764089_study-01,PMID35764089_protocol-01
16,-,PMID35764089_experimentID-02,"SARS-CoV-2 ELISA, post-vaccination",-,ELISA,PMID35764089_study-01,PMID35764089_protocol-01
17,-,PMID35764089_experimentID-03,"Pseudovirus (PSV) Neutralization Assay, pre-vaccination",-,Pseudovirus Neutralization Assay,PMID35764089_study-01,PMID35764089_protocol-01
18,-,PMID35764089_experimentID-04,"Pseudovirus (PSV) Neutralization Assay, post-vaccination",-,Pseudovirus Neutralization Assay,PMID35764089_study-01,PMID35764089_protocol-01
19,-,PMID35764089_experimentID-05,"Spike megapool (spike MP), pre-vaccination",-,Flow Cytometry,PMID35764089_study-01,PMID35764089_protocol-01
20,-,PMID35764089_experimentID-06,"Spike megapool (spike MP), post-vaccination",-,Flow Cytometry,PMID35764089_study-01,PMID35764089_protocol-01
21,-,PMID35764089_experimentID-07,"Activation-induced markers (AIM) assay, pre-vaccination",-,Cell Mediated Immunoassay,PMID35764089_study-01,PMID35764089_protocol-01
22,-,PMID35764089_experimentID-08,"Activation-induced markers (AIM) assay, post-vaccination",-,Cell Mediated Immunoassay,PMID35764089_study-01,PMID35764089_protocol-01
23,-,PMID35764089_experimentID-09,"Intracellular cytokine staining (ICS), pre-vaccination",-,Flow Cytometry,PMID35764089_study-01,PMID35764089_protocol-01
24,-,PMID35764089_experimentID-010,"Intracellular cytokine staining (ICS), post-vaccination",-,Flow Cytometry,PMID35764089_study-01,PMID35764089_protocol-01
25,-,PMID35764089_experimentID-011,"Detection of SARS-CoV-2-specific memory B cells, pre-vaccination",-,Flow Cytometry,PMID35764089_study-01,PMID35764089_protocol-01
26,-,PMID35764089_experimentID-012,"Detection of SARS-CoV-2-specific memory B cells, post-vaccination",-,Flow Cytometry,PMID35764089_study-01,PMID35764089_protocol-01
27,-,PMID35605428_experimentID-01,SARS-CoV-2 test,-,PCR,PMID35605428_study-01,PMID35605428_protocol-01
28,-,PMID35605428_experimentID-02,SARS-CoV-2 test,-,PCR,PMID35605428_study-01,PMID35605428_protocol-01
29,-,PMID35605428_experimentID-03,"Anti-spike, anti-RBD and anti-N assay",-,Multiplex Immunoassay,PMID35605428_study-01,PMID35605428_protocol-01
30,-,PMID35605428_experimentID-04,SARS-CoV-2 pseudovirus neutralisation assay,-,Pseudovirus Neutralization Assay,PMID35605428_study-01,PMID35605428_protocol-01
31,-,PMID35605428_experimentID-05,"Anti-spike, anti-RBD and anti-N assay",-,Multiplex Immunoassay,PMID35605428_study-01,PMID35605428_protocol-01
32,-,PMID35605428_experimentID-06,SARS-CoV-2 pseudovirus neutralisation assay,-,Pseudovirus Neutralization Assay,PMID35605428_study-01,PMID35605428_protocol-01
33,-,PMID35605428_experimentID-07,"Anti-spike, anti-RBD and anti-N assay",-,Multiplex Immunoassay,PMID35605428_study-01,PMID35605428_protocol-01
34,-,PMID35605428_experimentID-08,SARS-CoV-2 pseudovirus neutralisation assay,-,Pseudovirus Neutralization Assay,PMID35605428_study-01,PMID35605428_protocol-01
35,-,PMID34594341_experimentID-01,ELISA to Detect Anti-SARS-CoV-2 Antibodies in Plasma Samples,-,ELISA,PMID34594341_study-01,PMID34594341_protocol-01
36,-,PMID34594341_experimentID-02,Competition ELISA to Detect Antibodies That Block Binding of ACE2 to RBD,-,ELISA,PMID34594341_study-01,PMID34594341_protocol-01
37,-,PMID34594341_experimentID-03,Real-Time PCR for Detection of SARS-CoV-2 RNA in Plasma Samples,-,PCR,PMID34594341_study-01,PMID34594341_protocol-01
38,-,PMID34594341_experimentID-04,S-PLEX Direct Detection Assay,-,PCR,PMID34594341_study-01,PMID34594341_protocol-01
39,-,PMID34861167_experimentID-01,Electrochemiluminescence (ECL) IgG binding assay,-,Chemiluminescent Assay,PMID34861167_study-01,PMID34861167_protocol-01
40,-,PMID34861167_experimentID-02,Pseudovirus neutralization assay,-,Pseudovirus Neutralization Assay,PMID34861167_study-01,PMID34861167_protocol-01
41,-,PMID34861167_experimentID-03,ACE2-variant RBD antibody blocking assays,-,ELISA,PMID34861167_study-01,PMID34861167_protocol-01
42,-,PMID34861167_experimentID-04,SARS-CoV-2 variant genotyping,-,PCR,PMID34861167_study-01,PMID34861167_protocol-01
43,-,PMID32678685_experimentID-01,RT-PCR,-,PCR,PMID32678685_study-01,PMID32678685_protocol-02
44,-,PMID32678685_experimentID-02,Serologic testing for antibodies against the SARS-CoV-2 spike protein,-,ELISA,PMID32678685_study-01,PMID32678685_protocol-02
45,-,PMID32941787_experimentID-01,Viral and Serological Testing,-,ELISA,PMID32941787_study-01,PMID32941787_protocol-01
46,-,PMID32941787_experimentID-02,Viral and Serological Testing,-,ELISA,PMID32941787_study-01,PMID32941787_protocol-01
47,-,PMID32941787_experimentID-03,IGH Library Prep and Sequencing,-,IgH Sequencing,PMID32941787_study-01,PMID32941787_protocol-01
48,-,PMID32941787_experimentID-04,IGH Library Prep and Sequencing,-,IgH Sequencing,PMID32941787_study-01,PMID32941787_protocol-01
49,-,PMID32941787_experimentID-05,ELISA Testing of mAbs,-,ELISA,PMID32941787_study-01,PMID32941787_protocol-01
50,-,PMID32941787_experimentID-06,RT-PCR ,-,PCR,PMID32941787_study-01,PMID32941787_protocol-01
51,-,PMID35857529_experimentID-01,Surface plasmon resonance (SPR) assays,-,Surface Plasmon Resonance,PMID35857529_study-01,PMID35857529_protocol-01
52,-,PMID35857529_experimentID-02,Pseudotyped VSV neutralization assay - Post-vaccination,-,Pseudovirus Neutralization Assay,PMID35857529_study-01,PMID35857529_protocol-01
53,-,PMID35857529_experimentID-03,Pseudotyped VSV neutralization assay - Convalescent,-,Pseudovirus Neutralization Assay,PMID35857529_study-01,PMID35857529_protocol-01
54,-,PMID35857529_experimentID-04,Cell-cell Fusion Assay,-,Flow Cytometry,PMID35857529_study-01,PMID35857529_protocol-01
55,-,PMID35857529_experimentID-05,Enzyme-linked immunosorbent assay (ELISA) - Post vaccination,-,ELISA,PMID35857529_study-01,PMID35857529_protocol-01
56,-,PMID35857529_experimentID-06,Enzyme-linked immunosorbent assay (ELISA) - Convalescent,-,ELISA,PMID35857529_study-01,PMID35857529_protocol-01
57,-,PMID33822097_experimentID-01,CCC and SARS-CoV-2 ELISA-Post-symptom onset,-,ELISA,PMID33822097_study-01,PMID33822097_protocol-02
58,-,PMID33822097_experimentID-02,CCC and SARS-CoV-2 ELISA-Naïve,-,ELISA,PMID33822097_study-01,PMID33822097_protocol-02
59,-,PMID33822097_experimentID-03,CCC and SARS-CoV-2 nucleocapsid ELISA-Naïve,-,ELISA,PMID33822097_study-01,PMID33822097_protocol-02
60,-,PMID33822097_experimentID-04,Activation-induced cell marker (AIM) assays,-,Flow Cytometry,PMID33822097_study-01,PMID33822097_protocol-02
61,-,PMID33822097_experimentID-05,Activation-induced cell marker (AIM) assays,-,Flow Cytometry,PMID33822097_study-01,PMID33822097_protocol-02
62,-,PMID36480499_experimentID-01,SARS-CoV-2-nLUC viral neutralization assay,-,Neutralizing Antibody Titer Assay,PMID36480499_study-01,PMID36480499_protocol-01
63,-,PMID33798476_experimentID-01,Indirect enzyme-linked immunosorbent assays,-,ELISA,PMID33798476_study-01,PMID33798476_protocol-01
64,-,PMID33798476_experimentID-02,Microneutralization assay,-,Neutralizing Antibody Titer Assay,PMID33798476_study-01,PMID33798476_protocol-01
65,-,PMID33798476_experimentID-03,Western blot,-,Western Blot,PMID33798476_study-01,PMID33798476_protocol-01
66,-,PMID33798476_experimentID-04,Gene expression analysis,-,RNA Sequencing,PMID33798476_study-01,PMID33798476_protocol-01
67,-,PMID34951746_experimentID-01,EUROIMMUN anti-SARS-CoV-2 IgG enzyme-linked immunosorbent assay (ELISA) ,-,ELISA,PMID34951746_study-01,PMID34951746_protocol-01
68,-,PMID34951746_experimentID-02,MSD anti-spike IgG,-,ELISA,PMID34951746_study-01,PMID34951746_protocol-01
69,-,PMID34951746_experimentID-03,Pseudoneutralization/ACE2 inhibition assay,-,Pseudovirus Neutralization Assay,PMID34951746_study-01,PMID34951746_protocol-01
70,-,PMID34951746_experimentID-04,Neutralization assay,-,Neutralizing Antibody Titer Assay,PMID34951746_study-01,PMID34951746_protocol-01
71,-,PMID34951746_experimentID-05,Quantitative RT-PCR,-,PCR,PMID34951746_study-01,PMID34951746_protocol-01
72,-,PMID37264688_experimentID-01,Enzyme-linked immunosorbent assays (ELISA),-,ELISA,PMID37264688_study-01,PMID37264688_protocol-01
73,-,PMID37264688_experimentID-02,Avidity enzyme-linked immunosorbent assays (chaotrope ELISA),-,ELISA,PMID37264688_study-01,PMID37264688_protocol-01
74,-,PMID34862384_experimentID-01,Bead-based disruption assays,-,Multiplex Bead Array Assay,PMID34862384_study-01,PMID34862384_protocol-01
75,-,PMID34862384_experimentID-02,Biolayer interferometry assay,-,Bio-layer Interferometry Assay,PMID34862384_study-01,PMID34862384_protocol-01
76,-,PMID34862384_experimentID-03,X-ray crystallography,-,X-Ray Crystallography,PMID34862384_study-01,PMID34862384_protocol-01
77,-,PMID34862384_experimentID-04,Anaphylactogenicity,-,Flow Cytometry,PMID34862384_study-01,PMID34862384_protocol-01
78,-,PMID34862384_experimentID-05,Cryo-EM data collection and processing,-,Cryo-Electron Microscopy,PMID34862384_study-01,PMID34862384_protocol-01
79,-,PMID36597886_experimentID-01,Elecsys ProBNP 2 STAT Immunoassay,-,Other,PMID36597886_study-01,PMID36597886_protocol-01
80,-,PMID36597886_experimentID-02,Antigen-specific antibody titers assay,-,Single-Molecule Array (SIMOA),PMID36597886_study-01,PMID36597886_protocol-01
81,-,PMID36597886_experimentID-03,Fc receptor binding assay,-,Multiplex Bead Array Assay,PMID36597886_study-01,PMID36597886_protocol-01
82,-,PMID36597886_experimentID-04,Antibody-dependent complement deposition (ADCD) assay,-,Cell Mediated Immunoassay,PMID36597886_study-01,PMID36597886_protocol-01
83,-,PMID36597886_experimentID-05,Antibody-dependent cellular phagocytosis (ADCP) assay,-,Cell Mediated Immunoassay,PMID36597886_study-01,PMID36597886_protocol-01
84,-,PMID36597886_experimentID-06,Antibody-mediated neutrophil phagocytosis (ADNP) assay,-,Cell Mediated Immunoassay,PMID36597886_study-01,PMID36597886_protocol-01
85,-,PMID36597886_experimentID-07,VirScan,-,Sequencing,PMID36597886_study-01,PMID36597886_protocol-01
86,-,PMID36597886_experimentID-08,T cell analysis,-,Flow Cytometry,PMID36597886_study-01,PMID36597886_protocol-01
87,-,PMID36597886_experimentID-09,Intracellular cytokine staining (ICS) assay,-,Flow Cytometry,PMID36597886_study-01,PMID36597886_protocol-01
88,-,PMID36597886_experimentID-010,Array neutralization assay,-,Multiplex Bead Array Assay,PMID36597886_study-01,PMID36597886_protocol-01
89,-,PMID36597886_experimentID-011,SARS-CoV-2 antigen assays,-,Single-Molecule Array (SIMOA),PMID36597886_study-01,PMID36597886_protocol-01
90,-,PMID35102312_experimentID-01,Pseudovirus NAb assay,-,Pseudovirus Neutralization Assay,PMID35102312_study-01,PMID35102312_protocol-01
91,-,PMID35102312_experimentID-02,ELISA,-,ELISA,PMID35102312_study-01,PMID35102312_protocol-01
92,-,PMID35102312_experimentID-03,Enzyme-linked immunospot assay,-,ELISA,PMID35102312_study-01,PMID35102312_protocol-01
93,-,PMID35102312_experimentID-04,Intracellular cytokine staining assay,-,Flow Cytometry,PMID35102312_study-01,PMID35102312_protocol-01
94,-,PMID36208629_experimentID-01,Neutrophil purity flow cytometry,-,Flow Cytometry,PMID36208629_study-01,PMID36208629_protocol-01
95,-,PMID36208629_experimentID-02,Cell-free DNA (cfDNA) quantification,-,Chemiluminescent Assay,PMID36208629_study-01,PMID36208629_protocol-01
96,-,PMID36208629_experimentID-03,Smart-Seq2,-,RNA Sequencing,PMID36208629_study-01,PMID36208629_protocol-01
97,-,PMID36208629_experimentID-04,Citrullinated histone H3 ELISA,-,ELISA,PMID36208629_study-01,PMID36208629_protocol-01
98,-,PMID36208629_experimentID-05,Antibody subclass and isotype measurements,-,Multiplex Bead Array Assay,PMID36208629_study-01,PMID36208629_protocol-01
99,-,PMID36208629_experimentID-06,Antibody-dependent neutrophil phagocytosis (ADNP) assay,-,Cell Mediated Immunoassay,PMID36208629_study-01,PMID36208629_protocol-01
100,-,PMID36208629_experimentID-07,SARS-CoV-2 spike specific IgG and IgA isolation,-,ELISA,PMID36208629_study-01,PMID36208629_protocol-01
101,-,PMID36208629_experimentID-08,Antibody-dependent neutrophil activation and ROS release ,-,Chemiluminescent Assay,PMID36208629_study-01,PMID36208629_protocol-01
102,-,PMID36208629_experimentID-09,Neutrophil cell death imaging assay,-,Microscopy,PMID36208629_study-01,PMID36208629_protocol-01
103,-,PMID36208629_experimentID-010,Neutrophil PMA-treatment time-lapse microscopy,-,Microscopy,PMID36208629_study-01,PMID36208629_protocol-01
104,-,PMID36208629_experimentID-011,Neutrophil cell death induction and quantification,-,Cell Mediated Immunoassay,PMID36208629_study-01,PMID36208629_protocol-01
105,-,PMID36208629_experimentID-012,Neutrophil degranulation assay,-,Flow Cytometry,PMID36208629_study-01,PMID36208629_protocol-01
106,-,PMID37863065_experimentID-01,Meso Scale Discovery Assay,-,Chemiluminescent Assay,PMID37863065_study-01,PMID37863065_protocol-01
107,-,PMID37863065_experimentID-02,RT-PCR,-,PCR,PMID37863065_study-01,PMID37863065_protocol-01
108,-,PMID36192374_experimentID-01,Biolayer interferometry (BLI) binding assays,-,Bio-layer Interferometry Assay,PMID36192374_study-01,PMID36192374_protocol-01
109,-,PMID36192374_experimentID-02,ELISA,-,ELISA,PMID36192374_study-01,PMID36192374_protocol-01
110,-,PMID36192374_experimentID-03,Plaque reduction neutralization tests (PRNT),-,Plaque Reduction Neutralization Assay,PMID36192374_study-01,PMID36192374_protocol-01
111,-,PMID36192374_experimentID-04,Western Blot,-,Western Blot,PMID36192374_study-01,PMID36192374_protocol-01
112,-,PMID36192374_experimentID-05,Serum In Vitro Neutralization Assay,-,Pseudovirus Neutralization Assay,PMID36192374_study-01,PMID36192374_protocol-01
113,-,PMID36192374_experimentID-06,Virus Plaque Assay,-,Virus Plaque Assay,PMID36192374_study-01,PMID36192374_protocol-01
114,-,PMID36192374_experimentID-07,Histopathology,-,Histopathology,PMID36192374_study-01,PMID36192374_protocol-01
115,-,PMID36192374_experimentID-08,Electron microscopy,-,Microscopy,PMID36192374_study-01,PMID36192374_protocol-01
116,-,PMID36192374_experimentID-09,FACS S1 disassociation assay,-,Flow Cytometry,PMID36192374_study-01,PMID36192374_protocol-01
117,-,PMID36192374_experimentID-010,Cryo-EM,-,Cryo-Electron Microscopy,PMID36192374_study-01,PMID36192374_protocol-01
118,-,PMID37695910_experimentID-01,Negative Stain Electron Microscopy,-,Microscopy,PMID37695910_study-01,PMID37695910_protocol-01
119,-,PMID37695910_experimentID-02,Fluorescence Binding Experiments,-,Liquid Chromatography,PMID37695910_study-01,PMID37695910_protocol-01
120,-,PMID37695910_experimentID-03,NMR  Spectroscopy,-,NMR,PMID37695910_study-01,PMID37695910_protocol-01
121,-,PMID37695910_experimentID-04,Pseudovirus Inhibition Assays,-,Pseudovirus Neutralization Assay,PMID37695910_study-01,PMID37695910_protocol-01
122,-,PMID37695910_experimentID-05,SARS-CoV-2 Live Virus Neutralization Assays,-,Neutralizing Antibody Titer Assay,PMID37695910_study-01,PMID37695910_protocol-01
123,-,PMID37695910_experimentID-06,SARS- CoV 2003 Live Virus Neutralization Assays.,-,Neutralizing Antibody Titer Assay,PMID37695910_study-01,PMID37695910_protocol-01
